MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

19 May 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 122.91 millions, up 6.42% as compared to Rs. 115.50 millions during the corresponding quarter last year.Net profit for the quarter ended March 2025 increased significantly by 70.16% to Rs. 11.86 millions from Rs. 6.97 millions.A decline of 52.92 millions was observed in the OP in the quarter ended March 2025 from 53.38 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 122.91 115.50 6.42 466.72 448.81 3.99 466.72 448.81 3.99
Other Income 1.53 0.09 1600.00 48.05 0.39 12220.51 48.05 0.39 12220.51
PBIDT 52.92 53.38 -0.86 256.01 211.23 21.20 256.01 211.23 21.20
Interest 16.81 15.18 10.74 75.04 77.78 -3.52 75.04 77.78 -3.52
PBDT 36.11 38.20 -5.47 180.97 133.45 35.61 180.97 133.45 35.61
Depreciation 22.46 24.26 -7.42 90.17 92.91 -2.95 90.17 92.91 -2.95
PBT 13.65 13.94 -2.08 90.80 40.54 123.98 90.80 40.54 123.98
TAX 1.79 6.97 -74.32 15.11 15.32 -1.37 15.11 15.32 -1.37
Deferred Tax -3.10 -0.32 868.75 -5.72 -1.43 300.00 -5.72 -1.43 300.00
PAT 11.86 6.97 70.16 75.69 25.22 200.12 75.69 25.22 200.12
Equity 171.65 149.04 15.17 171.65 149.04 15.17 171.65 149.04 15.17
PBIDTM(%) 43.06 46.22 -6.84 54.85 47.06 16.55 54.85 47.06 16.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..